World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
74
Citations
24432
World Ranking
2075
National Ranking
29

Medicine

D-Index
74
Citations
24460
World Ranking
19319
National Ranking
277

Overview

Juan Fortea is affiliated with the Hospital de Sant Pau in Spain and has a substantial research output in the field of Medicine, with a focus on neurodegenerative diseases and related disorders. Their research spans several subfields, particularly Psychiatry and Mental Health, Physiology, Public Health, Environmental and Occupational Health, Neurology, and Epidemiology.

The scientist's work primarily addresses topics such as Dementia and Cognitive Impairment Research, Alzheimer's Disease Research and Treatments, Down Syndrome and Intellectual Disability Research, Chronic Disease Management Strategies, Frailty in Older Adults, Parkinson's Disease Mechanisms and Treatments, and Amyotrophic Lateral Sclerosis Research.

Some recent papers authored or co-authored by Juan Fortea include:

  • "Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology", 2024, JAMA Neurology
  • "Alzheimer's disease associated with Down syndrome: a genetic form of dementia", 2021, The Lancet Neurology
  • "Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study", 2020, The Lancet
  • "APOE4 homozygosity represents a distinct genetic form of Alzheimer's disease", 2024, Nature Medicine

Frequent co-authors in their body of work include:

  • Alberto Lleó
  • Daniel Alcolea
  • María Carmona-Iragui
  • Isabel Barroeta
  • Laura Videla

The scientist frequently publishes in notable venues such as:

  • Alzheimer's & Dementia
  • Alzheimer's Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Alzheimer's Disease
  • Neurology Perspectives

Best Publications

  • New insights into the genetic etiology of Alzheimer’s disease and related dementias

    Unknown

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.

    Gernot Kleinberger;Yoshinori Yamanishi;Marc Suárez-Calvet;Eva Czirr

  • Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

    Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

  • Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

    Unknown

  • sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

    Marc Suárez-Calvet;Marc Suárez-Calvet;Gernot Kleinberger;Miguel Ángel Araque Caballero;Matthias Brendel

  • Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

    Ganesh M. Babulal;Yakeel T. Quiroz;Benedict C. Albensi;Eider Arenaza-Urquijo

  • Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

    Ruth Chia;Marya S. Sabir;Sara Bandres-Ciga

  • Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

    Unknown

  • Alzheimer's disease associated with Down syndrome: a genetic form of dementia.

    Juan Fortea;Shahid H Zaman;Shahid H Zaman;Sigan Hartley;Michael S Rafii

  • Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Itziar de Rojas;Itziar de Rojas;Sonia Moreno-Grau;Sonia Moreno-Grau;Niccolo Tesi;Benjamin Grenier-Boley

  • Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

    Juan Fortea;Eduard Vilaplana;Maria Carmona-Iragui;Bessy Benejam

  • APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

    Unknown

  • Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.

    Mony J. de Leon;Yi Li;Nobuyuki Okamura;Wai H. Tsui

  • Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

    Alberto Lleó;Raúl Núñez-Llaves;Daniel Alcolea;Cristina Chiva

  • Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome

    Unknown

  • Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

    Juan Fortea;María Carmona-Iragui;Bessy Benejam;Susana Fernández

  • Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

    David Bergeron;David Bergeron;Maria L. Gorno-Tempini;Gil D. Rabinovici;Miguel A. Santos-Santos

  • Cortical microstructural changes along the Alzheimer's disease continuum

    Victor Montal;Eduard Vilaplana;Daniel Alcolea;Jordi Pegueroles

  • Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

    Andrew W Varga;Margaret E Wohlleber;Sandra Giménez;Sergio Romero;Sergio Romero

  • Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

    Marta Cosín-Tomás;Marta Cosín-Tomás;Anna Antonell;Albert Lladó;Daniel Alcolea

  • Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.

    Daniel Alcolea;Pablo Martínez-Lage;Pascual Sánchez-Juan;Javier Olazarán

  • Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers

    Juan Fortea;Roser Sala-Llonch;David Bartrés-Faz;Beatriz Bosch

  • Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

    Willemijn J Jansen;Rik Ossenkoppele;Betty M Tijms;Anne M Fagan

  • Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

    Oriol Dols-Icardo;Alberto García-Redondo;Ricard Rojas-García;Raquel Sánchez-Valle

Frequent Co-Authors

Alberto Lleó
Alberto Lleó Hospital de la Santa Creu i Sant Pau
Kaj Blennow
Kaj Blennow University of Gothenburg
Pau Pastor
Pau Pastor University of Navarra
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Lorena Rami
Lorena Rami University of Barcelona
Caroline Graff
Caroline Graff Karolinska University Hospital
Peter Paul De Deyn
Peter Paul De Deyn University of Antwerp
Sebastiaan Engelborghs
Sebastiaan Engelborghs University of Antwerp
Michael T. Heneka
Michael T. Heneka University Hospital Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Juan Fortea

Trending Scientists

Recently Published Articles